Cortex, Boston Scientific

Shares of Boston Scientific Corp. BSX inched 0.97% higher to $85.54 Tuesday, on what proved to be an all-around positive ...
Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...
Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...
Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.
Boston Scientific's strong history, margins, and pipeline make it a buy despite other analysts' Hold rating, with 15% growth ...
On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial ...
Boston Scientific (NYSE:BSX) today announced that a study of its Acurate neo2 aortic valve system missed its primary endpoint ...
Boston Scientific’s long-awaited transcatheter aortic heart valve missed its mark in a head-to-head study aimed at bringing the implant to the U.S.—but the company believ | Boston Scientific’s ...
In a report released today, Michael Matson from Needham maintained a Hold rating on Boston Scientific (BSX – Research Report). The ...
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...
Since rolling out its pulsed field ablation system for treating atrial fibrillation earlier this year, Boston Scientific has ...